September 2021
Diagnologix was awarded a Fast-Track SBIR award titled "
Toward GMP production of antigen specific regulatory T cells
".
(*
Financial Conflict of Interest Policy
)
September 2019
Diagnologix was awarded a Phase II SBIR Contract titled "
A SIMPLE END-TO-END SYSTEM FOR SERIAL CELL SORTING AND MANIPULATION USING A SINGLE CONTAINER
", which can be integrated in a cGMP environment.
September 2017
Diagnologix was awarded a Phase I SBIR Contract titled "
A SIMPLE END-TO-END SYSTEM FOR SERIAL CELL SORTING AND MANIPULATION USING A SINGLE CONTAINER
".
August 2017
Diagnologix was awarded a Phase II SBIR Grant titled "
AN INNOVATIVE SYSTEM FOR CORD BLOOD STEM CELL ISOLATION
".
May 2015
Diagnologix was awarded a Phase II SBIR Grant "
BUOYANCY BASED BIOSEPARATIONS
" for the development of technology to isolate circulating tumor cells.
November 2014
Diagnologix was awarded a Phase I SBIR Grant, titled "
AN INNOVATIVE SYSTEM FOR CORD BLOOD STEM CELL ISOLATION
".
September 2013
Diagnologix was awarded a Phase I SBIR Grant
Buoyancy Based Bioseparations
for the development of technology to isolate circulating tumor cells.